Search research articles
Contact Us
Filters
Showing results (101-110 of 199) with videos related to
Page
of 20
Sort By:
International Journal of Nanomedicine
|
January 8, 2015
Photo activation of HPPH encapsulated in "Pocket" liposomes triggers multiple drug release and tumor cell killing in mouse breast cancer xenografts
Jessica Sine, Cordula Urban, Derek Thayer, et al.
Neoplasia (New York, N.Y.)
|
September 9, 2010
Somatic expression of PyMT or activated ErbB2 induces estrogen-independent mammary tumorigenesis
Michael J Toneff, Zhijun Du, Jie Dong, et al.
Breast (Edinburgh, Scotland)
|
July 9, 2017
De-escalation of treatment in HER2-positive breast cancer: Determinants of response and mechanisms of resistance
Jamunarani Veeraraghavan, Carmine De Angelis, Jorge S Reis-Filho, et al.
Cancer Research
|
September 23, 2003
Estrogen-mediated down-regulation of E-cadherin in breast cancer cells
Steffi Oesterreich, Wanleng Deng, Shiming Jiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 23, 2003
New mechanisms of signal transduction inhibitor action: receptor tyrosine kinase down-regulation and blockade of signal transactivation
Adrian V Lee, Rachel Schiff, Xiaojiang Cui, et al.
NPJ Breast Cancer
|
July 30, 2025
Single-cell transcriptomics reveals biomarker heterogeneity linked to CDK4/6 Inhibitor resistance in breast cancer cell lines
Ilenia Migliaccio, Martina Bonechi, Dario Romagnoli, et al.
Breast Cancer Research and Treatment
|
February 21, 2014
Therapeutic potential of the dual EGFR/HER2 inhibitor AZD8931 in circumventing endocrine resistance
Gladys Morrison, Xiaoyong Fu, Martin Shea, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 9, 2005
Molecular changes in tamoxifen-resistant breast cancer: relationship between estrogen receptor, HER-2, and p38 mitogen-activated protein kinase
M Carolina Gutierrez, Simone Detre, Stephen Johnston, et al.
Cancer Research
|
February 14, 2018
Perspective on Circulating Tumor Cell Clusters: Why It Takes a Village to Metastasize
Mario Giuliano, Anum Shaikh, Hin Ching Lo, et al.
Cancer Research
|
May 17, 2003
Estrogen receptor beta protein in human breast cancer: correlation with clinical tumor parameters
Suzanne A W Fuqua, Rachel Schiff, Irma Parra, et al.
Page
of 20
Search research articles
Search
Showing results (101-110 of 199) with videos related to
Sort By:
Page
of 20
International Journal of Nanomedicine
|
January 8, 2015
Photo activation of HPPH encapsulated in "Pocket" liposomes triggers multiple drug release and tumor cell killing in mouse breast cancer xenografts
Jessica Sine, Cordula Urban, Derek Thayer, et al.
Neoplasia (New York, N.Y.)
|
September 9, 2010
Somatic expression of PyMT or activated ErbB2 induces estrogen-independent mammary tumorigenesis
Michael J Toneff, Zhijun Du, Jie Dong, et al.
Breast (Edinburgh, Scotland)
|
July 9, 2017
De-escalation of treatment in HER2-positive breast cancer: Determinants of response and mechanisms of resistance
Jamunarani Veeraraghavan, Carmine De Angelis, Jorge S Reis-Filho, et al.
Cancer Research
|
September 23, 2003
Estrogen-mediated down-regulation of E-cadherin in breast cancer cells
Steffi Oesterreich, Wanleng Deng, Shiming Jiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 23, 2003
New mechanisms of signal transduction inhibitor action: receptor tyrosine kinase down-regulation and blockade of signal transactivation
Adrian V Lee, Rachel Schiff, Xiaojiang Cui, et al.
NPJ Breast Cancer
|
July 30, 2025
Single-cell transcriptomics reveals biomarker heterogeneity linked to CDK4/6 Inhibitor resistance in breast cancer cell lines
Ilenia Migliaccio, Martina Bonechi, Dario Romagnoli, et al.
Breast Cancer Research and Treatment
|
February 21, 2014
Therapeutic potential of the dual EGFR/HER2 inhibitor AZD8931 in circumventing endocrine resistance
Gladys Morrison, Xiaoyong Fu, Martin Shea, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 9, 2005
Molecular changes in tamoxifen-resistant breast cancer: relationship between estrogen receptor, HER-2, and p38 mitogen-activated protein kinase
M Carolina Gutierrez, Simone Detre, Stephen Johnston, et al.
Cancer Research
|
February 14, 2018
Perspective on Circulating Tumor Cell Clusters: Why It Takes a Village to Metastasize
Mario Giuliano, Anum Shaikh, Hin Ching Lo, et al.
Cancer Research
|
May 17, 2003
Estrogen receptor beta protein in human breast cancer: correlation with clinical tumor parameters
Suzanne A W Fuqua, Rachel Schiff, Irma Parra, et al.
Page
of 20